Rayrise Healthcare is a leading pharmaceutical company that provided an extensive range of pharmaceutical tablets, they have well-furnished formulations of the pharmaceutical tablets under cleaned environment.

The pharmaceutical capsules are formulated by Rayrise Healthcare is the fast-growing leading pharmaceutical knowledge-based company. Their offered range has a longer shelf life and accurate composition.

Rayrise Healthcare offers CAFNAV 100 DT which is a Cefixime Dispersible Tablet. The efficacy and safety of Cefixime administered once daily compared favourably with Trimethoprim/ Sulphamethoxazole administered twice daily for acute urinary tract infection.

CEFNAV 200 DT is another brand that has been prepared by Rayrise Healthcare which contains Cefixime as the main ingredient. This Brand is indicated for CAP, UTI, SSTI, Chronic Bronchitis, Acute Otitis Media, and Typhoid Fever.

CEFNAV - AZ has the power of synergy in mixed infections as it is the combination of CEFIXIME & AZITHROMYCIN. This medication is prescribed in Skin & Soft Tissue Infections, Pharyngitis & Tonsillitis, Urinary Tract Infections, Community-Acquired Pneumonia, Nosocomial Pneumonia, and Acute Otitis Media.

CEFNAV – LB tablet is used for Bacterial infections, Urinary tract infections, Chronic bronchitis exacerbation, Gonorrhea, Pharyngitis, and Tonsillitis. Cefixime has broad-spectrum antibiotic with activity in both gram-positive and gram-negative organisms.

CEFUAM-500 tablet has the real power to destroy infections. This tablet is used in skin & soft tissue infection, bone & joint infection, urinary tract infection, ent infections, postoperative infections, and typhoid fever.

CITFOL- CT has full of strength, full of power for bones. Calcitriol stimulates intestinal calcium absorption, increases bone strength more effectively than Vitamin D3, and exerts bone-protective effects. Calcium Carbonate contains the highest elemental calcium. It possesses high bioavailability. Zinc is vital for foetal development and promotes bone mineral density.

ESNOCORT strikes the steroids dependent conditions. Deflazacort proves beneficial, its replacement of prednisone will be a great adavance in the treatment of juvenile rheumatoid arthritis & other steroid-dependent conditions.

RAYDOX – CV has the strengthened approach to get rid of resistant pathogens. It has efficacy beyond expectations against resistant pathogens. This combination impairs the emergence and spread of resistant pathogens.